Anticancer Therapy
Adding pembrolizumab to chemoradiotherapy improves outcomes in high-risk cervical cancer
The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced cervical cancer, according to data presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
‘Global problem’: Numerous factors, biases contribute to overtreatment at end of life
Nathan I. Cherny, MD, has worked all around the world.
‘Lose-lose-lose’ scenario: ASCO seeks reduced out-of-pocket costs for cancer care
Out-of-pocket costs like deductibles and copays deter people with cancer from complying with treatment.
Obe-cel improves EFS in advanced B-cell acute lymphoblastic leukemia
Obecabtagene autoleucel conferred durable benefit to certain patients with relapsed or refractory B-cell acute lymphoblastic leukemia, according to results of the phase 1B/phase 2 FLEIX study presented at ASCO Annual Meeting.
Findings highlight ‘desperate need’ to improve end-of-life cancer treatment
Oncologic treatment of adults with various metastatic or advanced solid tumors may not improve OS and could be detrimental to quality of life, according to findings published in JAMA Oncology.
Guidelines: Optimizing vaccinations a ‘critical component’ of effective cancer care
New guidelines for vaccinating adults with solid or hematologic cancers detailed the importance of vaccination optimization, multidisciplinary coordination and vaccination of household members.
Researchers evaluate lung cancer treatment that can be inhaled
Researchers at Columbia University's Herbert Irving Comprehensive Cancer Center are investigating a lung cancer treatment that can be delivered directly to the lungs.
New data ‘offer some hope’ that checkpoint inhibitors may be safe for pregnant women
Use of immune checkpoint inhibitors for pregnant women with cancer may be safer than previously thought, according to study results published in JAMA Network Open.
Supportive interventions improve endocrine therapy adherence for breast cancer survivors
For many breast cancer survivors, adjuvant endocrine therapy can substantially reduce the risk for recurrence.
AHA: Address biological mechanisms, diversity, biases to improve cardio-oncology care
Underrepresented groups face elevated cardiotoxic risk and strategies are needed to eliminate inequities in cardio-oncology research and clinical care, according to a scientific statement published in Circulation.